Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on the latest valid filing.
EIN 75-3170106 • 501(c)3 • Bethesda, MD
Profile
Enacct's mission is to improve access to cancer clinical trials through education and collaboration with communities, health care providers, and researchers. Enacct's vision is to achieve the highest quality cancer care and research through clinical trials.
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on the latest valid filing.
Liabilities / Revenue
62nd percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
4th percentile
Higher net margin than 4% of similar nonprofits.
Top Officer Pay
81st percentile
Higher top officer pay than 81% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
10th percentile
Faster asset growth than 10% of similar nonprofits.
Revenue Growth
5th percentile
Faster revenue growth than 5% of similar nonprofits.
Assets
Down$0
Down $118,509 (-100%) from 2013
Liabilities
Down$0
Down $22,321 (-100%) from 2013
Net Assets
Down$0
Down $96,188 (-100%) from 2013
Revenue
Down$15,255
Down $318,767 (-95%) from 2013
Expenses
Down$111,443
Down $312,668 (-74%) from 2013
Net Income
Down-$96,188
Down $6,099 (-6.8%) from 2013
Most recent year
2014 • Form 990Detailed filing. Detailed filing data is available for this year.
Enacct's mission is to improve access to cancer clinical trials through education and collaboration with communities, health care providers, and researchers. Enacct's vision is to achieve the highest quality cancer care and research through clinical trials.
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Savings and Temporary Cash Investments | $69,343 | - | - |
| Accounts Receivable | $45,832 | - | - |
| Cash and Non-Interest-Bearing Accounts | $2,034 | - | - |
| Total Assets | $118,509 | $0 | ▼ $118,509 |
| Other Assets Total | $1,300 | - | - |
| Liabilities | |||
| Accounts Payable and Accrued Expenses | $22,321 | - | - |
| Total Liabilities | $22,321 | $0 | ▼ $22,321 |
| Net Assets / Fund Balance | |||
| Unrestricted Net Assets | $96,188 | - | - |
| Total Net Assets Fund Balance | $96,188 | $0 | ▼ $96,188 |
| Total Liabilities and Net Assets / Fund Balance | $118,509 | $0 | ▼ $118,509 |
| Name | Title |
|---|---|
| Bonnie Crawford | Board Member |
| Carrie Jones | Board Member |
| Gwen Darien | Board Member |
| Loretta Irvin | Board Member |
| Maria Gonzalez | Board Member |
| Nila Saliba | Board Member |
| Robert Caine Md | Board Member |
| Line Item | Amount |
|---|---|
| Other Expenses | $75,533 |
| Salaries, Compensation, and Employee Benefits | $35,910 |
| Grants and Similar Amounts Paid | $0 |
| Professional Fundraising Fees | $0 |
| Total Fundraising Expense | $0 |
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Fees for Services Other | $55,876 | - | - | $55,876 |
| Current Officers, Directors, Trustees, and Key Employees | $21,310 | - | - | $21,310 |
| Other Salaries and Wages | $10,464 | - | - | $10,464 |
| Other Expenses | $5,770 | - | - | $5,770 |
| Fees for Services Legal | - | $5,218 | - | $5,218 |
| Fees for Services Accounting | - | $4,500 | - | $4,500 |
| Payroll Taxes | $3,498 | - | - | $3,498 |
| Insurance | - | $2,039 | - | $2,039 |
| Information Technology | $70 | $1,060 | - | $1,130 |
| Other Employee Benefits | $638 | - | - | $638 |
| Travel | - | $470 | - | $470 |
| Office Expenses | - | $330 | - | $330 |
| Occupancy | - | $200 | - | $200 |
| Total Functional Expenses | $97,626 | $13,817 | $0 | $111,443 |
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
“The 990 was reviewed by the executive director. All changes were incorporated.”
“Ennact's policy is reviewed yearly by staff through the employee manual and yearly evaluations. The policy is signed yearly by all board members.”
“There is a yearly review of comparable salaries from national non-profits and those in dc. Salary ranges are reviewed and approved by executive committee of board.”
“Upon request copies are made and sent out of irs form 990's and 1023's”
“Enacct's mission is to improve access to cancer clinical trials through education and collaboration with communities, health care providers, and researchers. Enacct's vision is to achieve the highest quality cancer care and research through clinical trials.”
“"developed a patient discussion guide for boston medical center. The guide is intended to assist navigators in discussing potential trial participation in the clinic setting. Bmc use of the guide is pending. "completed promotion and monitoring of cme-accredited online training developed in collaboration with the center for asian health. The course was designed for primary care providers serving asian patients to increase their knowledge of cancer clinical trials, encourage discussion with patients about trials, and refer patients to cancer care sites that offer trials. Programs "planned and completed the national cancer clinical trials collaborative learning network, a patient-centered quality improvement program to improve cancer clinical trial recruitment, accrual and retention. The learning network provided 19 research teams - from both community oncology practices and academic center - with tools and techniques to identify and capitalize on specific opportunities for improvement to expand accrual and increase efficiency. Utilizing lessons learned and feedback from the original pilot learning collaborative, enacct showed the feasibility of using the model for research teams to effectively evaluate and review their current procedures for gaps and leaks. "continued hosting a free, monthly policy webinar series which aimed to raise awareness and enhance understanding of significant policy issues impacting cancer clinical trial accrual. Through this series, enacct was able to continue its advocacy for system changes to facilitate all cancer patients being screened for available trials, all trial eligible patients being approached by the oncologist and all trial eligible patients interested in participation being successfully enrolled. A total of 12 webinars were completed, averaging nearly 300 registrants and each receiving very positive feedback. "implemented patient navigation in cancer clinical trials, a pilot demonstration program designed to promote patient self-advocacy, question- listing and communication about potential research participation in the clinical trial setting. With input from a national advisory committee, the pilot selected 2 performance sites, with each institution implementing the intervention and monitoring trial accrual over a six month period. Development "developed the 360 cancer trial accrual self-assessment tool. This tool is designed to help community cancer centers and networks evaluate and improve their own cancer clinical trials accrual using 7 critical dimensions. The 7 dimensions include: (1) mission, strategy and vision, (2) trial selection and initiation, (3) people and tools, (4) accrual processes and procedures, (5) finance and management, (6) community outreach, and (7) communication practices. This tool is designed as a guided analysis which can be completed online, ideally by the cancer research leadership team with data provided by the staff. It is designed to focus the attention of the leadership team on both qualitative and quantitative factors across the critical dimensions of an effective clinical trials process. The tool includes three elements: (1) excel based data collection tool allowing for easy compilation and evaluation of all data needed to complete the assessment, (2) a web-based assessment survey intended to be completed by the research leadership team, and (3) the quick 360 survey which consists of a subset of questions from the web-based assessment survey and is intended to be completed by accruing physicians and research staff not involved in completing the web-based assessment. This tool was tested among 19 research teams. 100% of the teams found the process of completing the self-assessment to be very or somewhat helpful, and 92% found the results to be very or somewhat helpful in strategically identifying areas for improvement in their processes. "competencies for clinical trial accrual professionals. Following extensive review of existing professional standards fo”
“Expert consultants 15,700 0 0 trainers 14,805 0 0 consultants 25,371 0 0”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | false |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 22321 |
| IRS990/AccountsReceivableGrp/BOYAmt | 0 | 45832 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | false |
| IRS990/ActivityOrMissionDesc | 0 | ENACCT'S MISSION IS TO IMPROVE ACCESS TO CANCER CLINICAL TRIALS THROUGH EDUCATION AND COLLABORATION WITH COMMUNITIES, HEALTH CARE PROVIDERS, AND RESEARCHERS. ENACCT'S VISION IS TO ACHIEVE THE HIGHEST QUALITY CANCER CARE AND RESEARCH THROUGH CLINICAL TRIALS. |
| IRS990/AllOtherContributionsAmt | 0 | 15146 |
| IRS990/AnnualDisclosureCoveredPrsnInd | 0 | true |
| IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | ENACCT - THE ORGANIZATION |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 3018937603 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 7625 WISCONSIN AVENUE 3RD FLOOR |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | BETHESDA |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | MD |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 20814 |
| IRS990/BusinessRlnWithFamMemInd | 0 | false |
| IRS990/BusinessRlnWithOfficerEntInd | 0 | false |
| IRS990/BusinessRlnWithOrgMemInd | 0 | false |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 2034 |
| IRS990/ChangeToOrgDocumentsInd | 0 | false |
| IRS990/CollectionsOfArtInd | 0 | false |
| IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt | 0 | 21310 |
| IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt | 0 | 21310 |
| IRS990/CompensationFromOtherSrcsInd | 0 | false |
| IRS990/CompensationProcessCEOInd | 0 | true |
| IRS990/CompensationProcessOtherInd | 0 | false |
| IRS990/ConflictOfInterestPolicyInd | 0 | true |
| IRS990/ConservationEasementsInd | 0 | false |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | false |
| IRS990/ContractTerminationInd | 0 | X |
| IRS990/CreditCounselingInd | 0 | false |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 15146 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 0 |
| IRS990/CYInvestmentIncomeAmt | 0 | 1 |
| IRS990/CYOtherExpensesAmt | 0 | 75533 |
| IRS990/CYOtherRevenueAmt | 0 | 108 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 0 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | -96188 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 35910 |
| IRS990/CYTotalExpensesAmt | 0 | 111443 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 0 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 15255 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | false |
| IRS990/DeductibleArtContributionInd | 0 | false |
| IRS990/DeductibleNonCashContriInd | 0 | false |
| IRS990/DelegationOfMgmtDutiesInd | 0 | false |
| IRS990/Desc | 0 | COMMUNITY TRAINING "HOSTED A FREE, LIVE INTERACTIVE WEB-BASED COMMUNITY AMBASSADOR TRAINING PROGRAM FOR 20 RESEARCH TEAMS. THE COMMUNITY AMBASSADOR TRAINING PROGRAM TRAINS COMMUNITY LEADERS TO RAISE AWARENESS AND INCREASING UNDERSTANDING OF CLINICAL TRIALS IN THEIR COMMUNITY. THE INTERACTIVE CORE CONTENT IS DESIGNED TO BE LOCALLY FOCUSED AND CULTURALLY TAILORED, TRAINING AMBASSADORS TO LEAD INFORMATION PRESENTATIONS ABOUT THE IMPORTANCE OF CANCER RESEARCH, ENCOURAGING INQUIRY ABOUT TRIALS AND "SPREADING THE WORD. THIS PEER-TO-PEER APPROACH ALLOWS FOR AN OPEN AND HONEST DIALOGUE ABOUT CLINICAL RESEARCH. HEALTH CARE PROVIDER TRAINING "DEVELOPED A PATIENT DISCUSSION GUIDE FOR BOSTON MEDICAL CENTER. THE GUIDE IS INTENDED TO ASSIST NAVIGATORS IN DISCUSSING POTENTIAL TRIAL PARTICIPATION IN THE CLINIC SETTING. BMC USE OF THE GUIDE IS PENDING. "COMPLETED PROMOTION AND MONITORING OF CME-ACCREDITED ONLINE TRAINING DEVELOPED IN COLLABORATION WITH THE CENTER FOR ASIAN HEALTH. THE COURSE WAS DESIGNED FOR PRIMARY CARE PROVIDERS SERVING ASIAN PATIENTS TO INCREASE THEIR KNOWLEDGE OF CANCER CLINICAL TRIALS, ENCOURAGE DISCUSSION WITH PATIENTS ABOUT TRIALS, AND REFER PATIENTS TO CANCER CARE SITES THAT OFFER TRIALS. PROGRAMS "PLANNED AND COMPLETED THE NATIONAL CANCER CLINICAL TRIALS COLLABORATIVE LEARNING NETWORK, A PATIENT-CENTERED QUALITY IMPROVEMENT PROGRAM TO IMPROVE CANCER CLINICAL TRIAL RECRUITMENT, ACCRUAL AND RETENTION. THE LEARNING NETWORK PROVIDED 19 RESEARCH TEAMS - FROM BOTH COMMUNITY ONCOLOGY PRACTICES AND ACADEMIC CENTER - WITH TOOLS AND TECHNIQUES TO IDENTIFY AND CAPITALIZE ON SPECIFIC OPPORTUNITIES FOR IMPROVEMENT TO EXPAND ACCRUAL AND INCREASE EFFICIENCY. UTILIZING LESSONS LEARNED AND FEEDBACK FROM THE ORIGINAL PILOT LEARNING COLLABORATIVE, ENACCT SHOWED THE FEASIBILITY OF USING THE MODEL FOR RESEARCH TEAMS TO EFFECTIVELY EVALUATE AND REVIEW THEIR CURRENT PROCEDURES FOR GAPS AND LEAKS. "CONTINUED HOSTING A FREE, MONTHLY POLICY WEBINAR SERIES WHICH AIMED TO RAISE AWARENESS AND ENHANCE UNDERSTANDING OF SIGNIFICANT POLICY ISSUES IMPACTING CANCER CLINICAL TRIAL ACCRUAL. THROUGH THIS SERIES, ENACCT WAS ABLE TO CONTINUE ITS ADVOCACY FOR SYSTEM CHANGES TO FACILITATE ALL CANCER PATIENTS BEING SCREENED FOR AVAILABLE TRIALS, ALL TRIAL ELIGIBLE PATIENTS BEING APPROACHED BY THE ONCOLOGIST AND ALL TRIAL ELIGIBLE PATIENTS INTERESTED IN PARTICIPATION BEING SUCCESSFULLY ENROLLED. A TOTAL OF 12 WEBINARS WERE COMPLETED, AVERAGING NEARLY 300 REGISTRANTS AND EACH RECEIVING VERY POSITIVE FEEDBACK. "IMPLEMENTED PATIENT NAVIGATION IN CANCER CLINICAL TRIALS, A PILOT DEMONSTRATION PROGRAM DESIGNED TO PROMOTE PATIENT SELF-ADVOCACY, QUESTION- LISTING AND COMMUNICATION ABOUT POTENTIAL RESEARCH PARTICIPATION IN THE CLINICAL TRIAL SETTING. WITH INPUT FROM A NATIONAL ADVISORY COMMITTEE, THE PILOT SELECTED 2 PERFORMANCE SITES, WITH EACH INSTITUTION IMPLEMENTING THE INTERVENTION AND MONITORING TRIAL ACCRUAL OVER A SIX MONTH PERIOD. DEVELOPMENT "DEVELOPED THE 360 CANCER TRIAL ACCRUAL SELF-ASSESSMENT TOOL. THIS TOOL IS DESIGNED TO HELP COMMUNITY CANCER CENTERS AND NETWORKS EVALUATE AND IMPROVE THEIR OWN CANCER CLINICAL TRIALS ACCRUAL USING 7 CRITICAL DIMENSIONS. THE 7 DIMENSIONS INCLUDE: (1) MISSION, STRATEGY AND VISION, (2) TRIAL SELECTION AND INITIATION, (3) PEOPLE AND TOOLS, (4) ACCRUAL PROCESSES AND PROCEDURES, (5) FINANCE AND MANAGEMENT, (6) COMMUNITY OUTREACH, AND (7) COMMUNICATION PRACTICES. THIS TOOL IS DESIGNED AS A GUIDED ANALYSIS WHICH CAN BE COMPLETED ONLINE, IDEALLY BY THE CANCER RESEARCH LEADERSHIP TEAM WITH DATA PROVIDED BY THE STAFF. IT IS DESIGNED TO FOCUS THE ATTENTION OF THE LEADERSHIP TEAM ON BOTH QUALITATIVE AND QUANTITATIVE FACTORS ACROSS THE CRITICAL DIMENSIONS OF AN EFFECTIVE CLINICAL TRIALS PROCESS. THE TOOL INCLUDES THREE ELEMENTS: (1) EXCEL BASED DATA COLLECTION TOOL ALLOWING FOR EASY COMPILATION AND EVALUATION OF ALL DATA NEEDED TO COMPLETE THE ASSESSMENT, (2) A WEB-BASED ASSESSMENT SURVEY INTENDED TO BE COMPLETED BY THE RESEARCH LEADER |
| IRS990/DescribedInSection501c3Ind | 0 | true |
| IRS990/DisregardedEntityInd | 0 | false |
| IRS990/DocumentRetentionPolicyInd | 0 | true |
| IRS990/DonorAdvisedFundInd | 0 | false |
| IRS990/ElectionOfBoardMembersInd | 0 | false |
| IRS990/EmployeeCnt | 0 | 2 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | true |
| IRS990/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990/ExpenseAmt | 0 | 97626 |
| IRS990/FamilyOrBusinessRlnInd | 0 | false |
| IRS990/FederalGrantAuditRequiredInd | 0 | false |
| IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt | 0 | 4500 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 4500 |
| IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt | 0 | 5218 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 5218 |
| IRS990/FeesForServicesOtherGrp/ProgramServicesAmt | 0 | 55876 |
| IRS990/FeesForServicesOtherGrp/TotalAmt | 0 | 55876 |
| IRS990/FinalReturnInd | 0 | X |
| IRS990/ForeignActivitiesInd | 0 | false |
| IRS990/ForeignFinancialAccountInd | 0 | false |
| IRS990/ForeignOfficeInd | 0 | false |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 3 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 4 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 5 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 6 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 5 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 6 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | BONNIE CRAWFORD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | NILA SALIBA |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | GWEN DARIEN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 3 | CARRIE JONES |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 4 | ROBERT CAINE MD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 5 | LORETTA IRVIN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 6 | MARIA GONZALEZ |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 3 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 4 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 5 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 6 | BOARD MEMBER |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | false |
| IRS990/FormationYr | 0 | 2004 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | false |
| IRS990/FSAuditedInd | 0 | false |
| IRS990/FundraisingActivitiesInd | 0 | false |
| IRS990/GamingActivitiesInd | 0 | false |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 8 |
| IRS990/GrantsToIndividualsInd | 0 | false |
| IRS990/GrantsToOrganizationsInd | 0 | false |
| IRS990/GrantToRelatedPersonInd | 0 | false |
| IRS990/GrossReceiptsAmt | 0 | 15255 |
| IRS990/GroupReturnForAffiliatesInd | 0 | false |
| IRS990/IncludeFIN48FootnoteInd | 0 | false |
| IRS990/IndependentAuditFinclStmtInd | 0 | false |
| IRS990/IndependentVotingMemberCnt | 0 | 7 |
| IRS990/IndoorTanningServicesInd | 0 | false |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartIXInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt | 0 | 1060 |
| IRS990/InformationTechnologyGrp/ProgramServicesAmt | 0 | 70 |
| IRS990/InformationTechnologyGrp/TotalAmt | 0 | 1130 |
| IRS990/InsuranceGrp/ManagementAndGeneralAmt | 0 | 2039 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 2039 |
| IRS990/InvestmentIncomeGrp/ExclusionAmt | 0 | 1 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 1 |
| IRS990/InvestmentInJointVentureInd | 0 | false |
| IRS990/IRPDocumentCnt | 0 | 9 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LegalDomicileStateCd | 0 | MD |
| IRS990/LoanOutstandingInd | 0 | false |
| IRS990/LobbyingActivitiesInd | 0 | false |
| IRS990/LocalChaptersInd | 0 | false |
| IRS990/MaterialDiversionOrMisuseInd | 0 | false |
| IRS990/MembersOrStockholdersInd | 0 | false |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | true |
| IRS990/MinutesOfGoverningBodyInd | 0 | true |
| IRS990/MissionDesc | 0 | ENACCT'S MISSION IS TO IMPROVE ACCESS TO CANCER CLINICAL TRIALS THROUGH EDUCATION AND COLLABORATION WITH COMMUNITIES, HEALTH CARE PROVIDERS, AND RESEARCHERS. ENACCT'S VISION IS TO ACHIEVE THE HIGHEST QUALITY CANCER CARE AND RESEARCH THROUGH CLINICAL TRIALS. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | false |
| IRS990/MoreThan5000KToOrgInd | 0 | false |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 96188 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 0 |
| IRS990/NoListedPersonsCompensatedInd | 0 | X |
| IRS990/NondeductibleContributionsInd | 0 | false |
| IRS990/OccupancyGrp/ManagementAndGeneralAmt | 0 | 200 |
| IRS990/OccupancyGrp/TotalAmt | 0 | 200 |
| IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt | 0 | 330 |
| IRS990/OfficeExpensesGrp/TotalAmt | 0 | 330 |
| IRS990/OfficerMailingAddressInd | 0 | false |
| IRS990/OperateHospitalInd | 0 | false |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsSFAS117Ind | 0 | X |
| IRS990/OtherAssetsTotalGrp/BOYAmt | 0 | 1300 |
| IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt | 0 | 638 |
| IRS990/OtherEmployeeBenefitsGrp/TotalAmt | 0 | 638 |
| IRS990/OtherExpensesGrp/Desc | 0 | MISCELLANEOUS |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 5770 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 5770 |
| IRS990/OtherRevenueMiscGrp/Desc | 0 | REIMBURSED EXPENSES |
| IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt | 0 | 108 |
| IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt | 0 | 108 |
| IRS990/OtherRevenueTotalAmt | 0 | 108 |
| IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt | 0 | 10464 |
| IRS990/OtherSalariesAndWagesGrp/TotalAmt | 0 | 10464 |
| IRS990/PartialLiquidationInd | 0 | false |
| IRS990/PayrollTaxesGrp/ProgramServicesAmt | 0 | 3498 |
| IRS990/PayrollTaxesGrp/TotalAmt | 0 | 3498 |
| IRS990/PoliticalCampaignActyInd | 0 | false |
| IRS990/PrincipalOfficerNm | 0 | MARGO MICHAELS |
| IRS990/ProfessionalFundraisingInd | 0 | false |
| IRS990/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990/PYContributionsGrantsAmt | 0 | 270627 |
| IRS990/PYExcessBenefitTransInd | 0 | false |
| IRS990/PYInvestmentIncomeAmt | 0 | 113 |
| IRS990/PYOtherExpensesAmt | 0 | 235925 |
| IRS990/PYOtherRevenueAmt | 0 | 3782 |
| IRS990/PYProgramServiceRevenueAmt | 0 | 59500 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | -90089 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 188186 |
| IRS990/PYTotalExpensesAmt | 0 | 424111 |
| IRS990/PYTotalRevenueAmt | 0 | 334022 |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | -96188 |
| IRS990/RegularMonitoringEnfrcInd | 0 | true |
| IRS990/RelatedEntityInd | 0 | false |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990/ReportInvestmentsOtherSecInd | 0 | false |
| IRS990/ReportLandBuildingEquipmentInd | 0 | false |
| IRS990/ReportOtherAssetsInd | 0 | false |
| IRS990/ReportOtherLiabilitiesInd | 0 | false |
| IRS990/ReportProgramRelatedInvstInd | 0 | false |
| IRS990/SavingsAndTempCashInvstGrp/BOYAmt | 0 | 69343 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt | 0 | 15146 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt | 0 | 270627 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 317915 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 632409 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 951097 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt | 0 | 2187194 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt | 0 | 1 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt | 0 | 113 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 416 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 565 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 1419 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt | 0 | 2514 |
| IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt | 0 | 434521 |
| IRS990ScheduleA/PublicOrganization170Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY170Pct | 0 | 0.61730 |
| IRS990ScheduleA/PublicSupportPY170Pct | 0 | 0.69830 |
| IRS990ScheduleA/PublicSupportTotal170Amt | 0 | 1351708 |
| IRS990ScheduleA/SubstantialContributorsTotAmt | 0 | 835486 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind | 0 | X |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt | 0 | 15146 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt | 0 | 270627 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 317915 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 632409 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 951097 |
| IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt | 0 | 2187194 |
| IRS990ScheduleA/TotalSupportAmt | 0 | 2189708 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990/ScheduleBRequiredInd | 0 | true |
| IRS990/ScheduleJRequiredInd | 0 | false |
| IRS990ScheduleN/AssetsDistributedInd | 0 | true |
| IRS990ScheduleN/BondsOutstandingInd | 0 | false |
| IRS990ScheduleN/DirectorOfSuccessorInd | 0 | false |
| IRS990ScheduleN/EmployeeOfSuccessorInd | 0 | false |
| IRS990ScheduleN/LiabilitiesPaidInd | 0 | true |
| IRS990ScheduleN/OwnerOfSuccessorInd | 0 | false |
| IRS990ScheduleN/ReceiveCompensationInd | 0 | false |
| IRS990ScheduleN/RequiredToNotifyAGInd | 0 | false |
| IRS990/ScheduleORequiredInd | 0 | true |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | ENACCT'S MISSION IS TO IMPROVE ACCESS TO CANCER CLINICAL TRIALS THROUGH EDUCATION AND COLLABORATION WITH COMMUNITIES, HEALTH CARE PROVIDERS, AND RESEARCHERS. ENACCT'S VISION IS TO ACHIEVE THE HIGHEST QUALITY CANCER CARE AND RESEARCH THROUGH CLINICAL TRIALS. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | "DEVELOPED A PATIENT DISCUSSION GUIDE FOR BOSTON MEDICAL CENTER. THE GUIDE IS INTENDED TO ASSIST NAVIGATORS IN DISCUSSING POTENTIAL TRIAL PARTICIPATION IN THE CLINIC SETTING. BMC USE OF THE GUIDE IS PENDING. "COMPLETED PROMOTION AND MONITORING OF CME-ACCREDITED ONLINE TRAINING DEVELOPED IN COLLABORATION WITH THE CENTER FOR ASIAN HEALTH. THE COURSE WAS DESIGNED FOR PRIMARY CARE PROVIDERS SERVING ASIAN PATIENTS TO INCREASE THEIR KNOWLEDGE OF CANCER CLINICAL TRIALS, ENCOURAGE DISCUSSION WITH PATIENTS ABOUT TRIALS, AND REFER PATIENTS TO CANCER CARE SITES THAT OFFER TRIALS. PROGRAMS "PLANNED AND COMPLETED THE NATIONAL CANCER CLINICAL TRIALS COLLABORATIVE LEARNING NETWORK, A PATIENT-CENTERED QUALITY IMPROVEMENT PROGRAM TO IMPROVE CANCER CLINICAL TRIAL RECRUITMENT, ACCRUAL AND RETENTION. THE LEARNING NETWORK PROVIDED 19 RESEARCH TEAMS - FROM BOTH COMMUNITY ONCOLOGY PRACTICES AND ACADEMIC CENTER - WITH TOOLS AND TECHNIQUES TO IDENTIFY AND CAPITALIZE ON SPECIFIC OPPORTUNITIES FOR IMPROVEMENT TO EXPAND ACCRUAL AND INCREASE EFFICIENCY. UTILIZING LESSONS LEARNED AND FEEDBACK FROM THE ORIGINAL PILOT LEARNING COLLABORATIVE, ENACCT SHOWED THE FEASIBILITY OF USING THE MODEL FOR RESEARCH TEAMS TO EFFECTIVELY EVALUATE AND REVIEW THEIR CURRENT PROCEDURES FOR GAPS AND LEAKS. "CONTINUED HOSTING A FREE, MONTHLY POLICY WEBINAR SERIES WHICH AIMED TO RAISE AWARENESS AND ENHANCE UNDERSTANDING OF SIGNIFICANT POLICY ISSUES IMPACTING CANCER CLINICAL TRIAL ACCRUAL. THROUGH THIS SERIES, ENACCT WAS ABLE TO CONTINUE ITS ADVOCACY FOR SYSTEM CHANGES TO FACILITATE ALL CANCER PATIENTS BEING SCREENED FOR AVAILABLE TRIALS, ALL TRIAL ELIGIBLE PATIENTS BEING APPROACHED BY THE ONCOLOGIST AND ALL TRIAL ELIGIBLE PATIENTS INTERESTED IN PARTICIPATION BEING SUCCESSFULLY ENROLLED. A TOTAL OF 12 WEBINARS WERE COMPLETED, AVERAGING NEARLY 300 REGISTRANTS AND EACH RECEIVING VERY POSITIVE FEEDBACK. "IMPLEMENTED PATIENT NAVIGATION IN CANCER CLINICAL TRIALS, A PILOT DEMONSTRATION PROGRAM DESIGNED TO PROMOTE PATIENT SELF-ADVOCACY, QUESTION- LISTING AND COMMUNICATION ABOUT POTENTIAL RESEARCH PARTICIPATION IN THE CLINICAL TRIAL SETTING. WITH INPUT FROM A NATIONAL ADVISORY COMMITTEE, THE PILOT SELECTED 2 PERFORMANCE SITES, WITH EACH INSTITUTION IMPLEMENTING THE INTERVENTION AND MONITORING TRIAL ACCRUAL OVER A SIX MONTH PERIOD. DEVELOPMENT "DEVELOPED THE 360 CANCER TRIAL ACCRUAL SELF-ASSESSMENT TOOL. THIS TOOL IS DESIGNED TO HELP COMMUNITY CANCER CENTERS AND NETWORKS EVALUATE AND IMPROVE THEIR OWN CANCER CLINICAL TRIALS ACCRUAL USING 7 CRITICAL DIMENSIONS. THE 7 DIMENSIONS INCLUDE: (1) MISSION, STRATEGY AND VISION, (2) TRIAL SELECTION AND INITIATION, (3) PEOPLE AND TOOLS, (4) ACCRUAL PROCESSES AND PROCEDURES, (5) FINANCE AND MANAGEMENT, (6) COMMUNITY OUTREACH, AND (7) COMMUNICATION PRACTICES. THIS TOOL IS DESIGNED AS A GUIDED ANALYSIS WHICH CAN BE COMPLETED ONLINE, IDEALLY BY THE CANCER RESEARCH LEADERSHIP TEAM WITH DATA PROVIDED BY THE STAFF. IT IS DESIGNED TO FOCUS THE ATTENTION OF THE LEADERSHIP TEAM ON BOTH QUALITATIVE AND QUANTITATIVE FACTORS ACROSS THE CRITICAL DIMENSIONS OF AN EFFECTIVE CLINICAL TRIALS PROCESS. THE TOOL INCLUDES THREE ELEMENTS: (1) EXCEL BASED DATA COLLECTION TOOL ALLOWING FOR EASY COMPILATION AND EVALUATION OF ALL DATA NEEDED TO COMPLETE THE ASSESSMENT, (2) A WEB-BASED ASSESSMENT SURVEY INTENDED TO BE COMPLETED BY THE RESEARCH LEADERSHIP TEAM, AND (3) THE QUICK 360 SURVEY WHICH CONSISTS OF A SUBSET OF QUESTIONS FROM THE WEB-BASED ASSESSMENT SURVEY AND IS INTENDED TO BE COMPLETED BY ACCRUING PHYSICIANS AND RESEARCH STAFF NOT INVOLVED IN COMPLETING THE WEB-BASED ASSESSMENT. THIS TOOL WAS TESTED AMONG 19 RESEARCH TEAMS. 100% OF THE TEAMS FOUND THE PROCESS OF COMPLETING THE SELF-ASSESSMENT TO BE VERY OR SOMEWHAT HELPFUL, AND 92% FOUND THE RESULTS TO BE VERY OR SOMEWHAT HELPFUL IN STRATEGICALLY IDENTIFYING AREAS FOR IMPROVEMENT IN THEIR PROCESSES. "COMPETENCIES FOR CLINICAL TRIAL ACCRUAL PROFESSIONALS. FOLLOWING EXTENSIVE REVIEW OF EXISTING PROFESSIONAL STANDARDS FO |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | THE 990 WAS REVIEWED BY THE EXECUTIVE DIRECTOR. ALL CHANGES WERE INCORPORATED. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | ENNACT'S POLICY IS REVIEWED YEARLY BY STAFF THROUGH THE EMPLOYEE MANUAL AND YEARLY EVALUATIONS. THE POLICY IS SIGNED YEARLY BY ALL BOARD MEMBERS. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | THERE IS A YEARLY REVIEW OF COMPARABLE SALARIES FROM NATIONAL NON-PROFITS AND THOSE IN DC. SALARY RANGES ARE REVIEWED AND APPROVED BY EXECUTIVE COMMITTEE OF BOARD. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | UPON REQUEST COPIES ARE MADE AND SENT OUT OF IRS FORM 990'S AND 1023'S |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 6 | EXPERT CONSULTANTS 15,700 0 0 TRAINERS 14,805 0 0 CONSULTANTS 25,371 0 0 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990 - ORGANIZATION'S MISSION |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990, PAGE 2, PART III, LINE 4A |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990, PAGE 6, PART VI, LINE 11B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990, PAGE 6, PART VI, LINE 12C |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990, PAGE 6, PART VI, LINE 15A |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | FORM 990, PAGE 6, PART VI, LINE 19 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 6 | FORM 990, PART IX, LINE 11G |
| IRS990/SchoolOperatingInd | 0 | false |
| IRS990/SignificantChangeInd | 0 | false |
| IRS990/SignificantNewProgramSrvcInd | 0 | false |
| IRS990/SubjectToProxyTaxInd | 0 | false |
| IRS990/TaxablePartyNotificationInd | 0 | false |
| IRS990/TaxExemptBondsInd | 0 | false |
| IRS990/TempOrPermanentEndowmentsInd | 0 | false |
| IRS990/TerminateOperationsInd | 0 | true |
| IRS990/TotalAssetsBOYAmt | 0 | 118509 |
| IRS990/TotalAssetsEOYAmt | 0 | 0 |
| IRS990/TotalAssetsGrp/BOYAmt | 0 | 118509 |
| IRS990/TotalAssetsGrp/EOYAmt | 0 | 0 |
| IRS990/TotalCompGreaterThan150KInd | 0 | false |
| IRS990/TotalContributionsAmt | 0 | 15146 |
| IRS990/TotalEmployeeCnt | 0 | 2 |
| IRS990/TotalFunctionalExpensesGrp/FundraisingAmt | 0 | 0 |
| IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt | 0 | 13817 |
| IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt | 0 | 97626 |
| IRS990/TotalFunctionalExpensesGrp/TotalAmt | 0 | 111443 |
| IRS990/TotalGrossUBIAmt | 0 | 0 |
| IRS990/TotalLiabilitiesBOYAmt | 0 | 22321 |
| IRS990/TotalLiabilitiesEOYAmt | 0 | 0 |
| IRS990/TotalLiabilitiesGrp/BOYAmt | 0 | 22321 |
| IRS990/TotalLiabilitiesGrp/EOYAmt | 0 | 0 |
| IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt | 0 | 96188 |
| IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt | 0 | 0 |
| IRS990/TotalProgramServiceExpensesAmt | 0 | 97626 |
| IRS990/TotalRevenueGrp/ExclusionAmt | 0 | 1 |
| IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 108 |
| IRS990/TotalRevenueGrp/TotalRevenueColumnAmt | 0 | 15255 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt | 0 | 118509 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt | 0 | 0 |
| IRS990/TravelGrp/ManagementAndGeneralAmt | 0 | 470 |
| IRS990/TravelGrp/TotalAmt | 0 | 470 |
| IRS990/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990/TypeOfOrganizationCorpInd | 0 | X |
| IRS990/UnrelatedBusIncmOverLimitInd | 0 | false |
| IRS990/UnrestrictedNetAssetsGrp/BOYAmt | 0 | 96188 |
| IRS990/UponRequestInd | 0 | X |
| IRS990/USAddress/AddressLine1Txt | 0 | 7625 WISCONSIN AVENUE 3RD FLOOR |
| IRS990/USAddress/CityNm | 0 | BETHESDA |
| IRS990/USAddress/StateAbbreviationCd | 0 | MD |
| IRS990/USAddress/ZIPCd | 0 | 20814 |
| IRS990/VotingMembersGoverningBodyCnt | 0 | 8 |
| IRS990/VotingMembersIndependentCnt | 0 | 7 |
| IRS990/WebsiteAddressTxt | 0 | WWW.ENACCT.ORG |
| IRS990/WhistleblowerPolicyInd | 0 | true |
| ReturnHeader/BuildTS | 0 | 2016-04-25 22:37:26Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | MARGO MICHAELS |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | EXEC DIR AND PRES OF BOARD |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 3018937603 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2015-11-15 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | EDUCATION NETWORK TO ADVANCE CANCER |
| ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt | 0 | CLINICAL TRIALS |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | EDUC |
| ReturnHeader/Filer/EIN | 0 | 753170106 |
| ReturnHeader/Filer/PhoneNum | 0 | 3018937603 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 7625 WISCONSIN AVENUE 3RD FLOOR |
| ReturnHeader/Filer/USAddress/CityNm | 0 | BETHESDA |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | MD |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 20814 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 521639708 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | COATES & HUTCHINSON PC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | P O BOX 561 |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | ODENTON |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | MD |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 21113 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 4107213946 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2015-11-16 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | THERESA HUTCHINSON |
| ReturnHeader/ReturnTs | 0 | 2015-11-16T14:25:35-06:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990 |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2014-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2014-12-31 |
| ReturnHeader/TaxYr | 0 | 2014 |
No mirrored PDF or thumbnail assets are attached yet.
Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • <$500k nonprofits
Helena, AR
View Organization501(c)3
Revenue vs current organization
About the sameAssets vs current organization
No dataNewport, TN
View Organization501(c)3
Revenue vs current organization
99% lowerAssets vs current organization
No dataChamberlain, SD
View Organization501(c)3
Revenue vs current organization
About the sameAssets vs current organization
No dataLocation unavailable
View Organization501(c)3
Revenue vs current organization
About the sameAssets vs current organization
No data